NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Acies Bio

Acies Bio

Private
LjubljanaHealthcare & Life Scienceshttps://www.aciesbio.com/

Last Round

Corporate Funding

Oct 22, 2021

Total Funding Raised

$2.07M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Acies Bio is a biotechnology company that provides research, development, and contract manufacturing services for microbial biotechnology, synthetic biology, and precision fermentation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROCDMOcontract development and manufacturing organizationmicrobial strain engineeringfermentation process developmentindustrial biotechnologysynthetic biologysynbiobio-based chemicalsbioprocess optimizationhigh-throughput screeningbioinformaticsmicrofluidicsbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Acies Bio Comparables

Compare Acies Bio with similar companies based on industry and business-model similarity.

Acies Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Abolis
85%
Conagen
78%
Bota Biosciences
76%

Acies Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingOct 22, 2021
GrantMay 3, 2018
GrantJul 6, 2017
GrantJan 15, 2016

Key People

Founding team and executive leadership

Štefan Fujs

CEO

Executive Team

Acies Bio Investors

Notable investors and investment history

Acies Bio investors
InvestorRounds
Ministry of the Economy, Tourism and SportGrant
ADM VenturesCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Monthly visitors grew 416% MoM, from 398 to 2.1K.

  • May 3, 2018

    Received grant funding from the European Union and SPIRIT Slovenia.

Acies Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Acies Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Acies Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLjubljana
Employee Range79
Year Founded2006
Last FundingOct 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.